findmyKOL

Charles Presti, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI↗
✓ Full record
RegionFort Wayne, IN · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication1992Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Charles Presti is a Cardiology physician. OpenAlex indexes 13 publications with 897 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

897citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

11108 Parkview Circle Dr
Fort Wayne, IN 468451730

Telephone

260-266-5700

Provider last certified this registry record 3 Oct 2022.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.2%
    Beta blocker21.3%
    Metoprolol Succinate54%Carvedilol28%Atenolol9%Metoprolol Tartrate9%
    Part D≥197 patients
    Statin19.6%
    Atorvastatin Calcium49%Rosuvastatin Calcium34%Pravastatin Sodium11%Simvastatin6%
    Part D≥166 patients

    + 16 more classes in this area

  • Blood & clotting

    14.8%
    Factor Xa inhibitor10.6%
    Eliquis81%Xarelto19%
    Part D≥121 patients
    P2Y12 inhibitor3.9%
    Clopidogrel100%
    Part D≥67 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.7%
    Potassium supplement1.7%
    Potassium Chloride87%Klor-Con M2013%
    Part D<11 patients
    SGLT2 inhibitor0.6%
    Jardiance58%Farxiga42%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)58.1% facility · 41.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”